Kyrgyzstan vs Myanmar: Treatment success rate for patients treated for MDR-TB
Kyrgyzstan
75.0%
in 2022
Myanmar
75.0%
in 2022
Kyrgyzstan rank
70th
Myanmar rank
70th
Treatment success rate for patients treated for MDR-TB over time
- Kyrgyzstan
- Myanmar
How they compare
Kyrgyzstan currently reports 75.0% against 75.0% in Myanmar, a difference of 0.0%.
Across all 14 years both countries report, Myanmar has been ahead every year.
Kyrgyzstan ranks 70th and Myanmar ranks 70th of 163 countries.
Myanmar has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Kyrgyzstan | Myanmar | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 35.0% | 73.0% | 38.0% | Myanmar |
| 2010s | 57.1% | 77.6% | 20.5% | Myanmar |
| 2020s | 74.0% | 75.3% | 1.3% | Myanmar |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Kyrgyzstan or Myanmar?
- Kyrgyzstan, at 75.0% against 75.0% in Myanmar as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Kyrgyzstan and Myanmar?
- 0.0%, with Kyrgyzstan ahead.
- How many years of comparable data are there for Kyrgyzstan and Myanmar?
- 14 years are reported by both, from 2009 to 2022.
- How do Kyrgyzstan and Myanmar rank globally for treatment success rate for patients treated for mdr-tb?
- Kyrgyzstan ranks 70th and Myanmar ranks 70th of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.